Skip to main content
All lobbying filings

THORN RUN PARTNERS

Lobbying for AMBIOPHARM INC. · Pharmaceutical manufacturing company.

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Income
$80,000.00
What the client paid this registrant for the period.
Client based in
South Carolina

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 3
Pharmacy

Advocacy related to U.S. trade, tax, and manufacturing policy, including matters affecting pharmaceutical manufacturing, supply chain resilience, and domestic production of active pharmaceutical ingredients (APIs).

Taxation/Internal Revenue Code

Advocacy related to U.S. trade, tax, and manufacturing policy, including matters affecting pharmaceutical manufacturing, supply chain resilience, and domestic production of active pharmaceutical ingredients (APIs).

Trade (domestic/foreign)

Advocacy related to U.S. trade, tax, and manufacturing policy, including matters affecting pharmaceutical manufacturing, supply chain resilience, and domestic production of active pharmaceutical ingredients (APIs).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem